Add like
Add dislike
Add to saved papers

The Cerna Network of Long Non-Coding RNA PCAT1/Mir-128-3p/SEC61A1 In Colon Cancer Cell Proliferation and Invasion.

BACKGROUND: Colon cancer (CC) remains a highly malignant cancer, with long non-coding RNAs (lncRNAs) associated with its molecular etiology.

OBJECTIVE: This study sought to investigate the mechanism of lncRNA prostate cancer-associated transcript 1 (lncRNA PCAT1) in CC cell proliferation and invasion and provide a theoretical reference for CC treatment.

METHODS: Expression levels of lncRNA PCAT1, microRNA (miR)-128-3p, and SEC61 translocon subunit alpha 1 (SEC61A1) were determined by RT-qPCR. Cell proliferation and invasion were evaluated by cell counting kit-8, colony formation, and Transwell assays. The subcellular fractionation assay analyzed the subcellular localization of lncRNA PCAT1. Dual-luciferase and RNA pull-down assays analyzed the binding of miR-128-3p to lncRNA PCAT1 and SEC61A1. Collaborative experiments were performed with miR-128-3p downregulation or SEC61A1 overexpression in si-PCAT1-treated CC cells.

RESULTS: LncRNA PCAT1 was upregulated in CC cells, and downregulation of lncRNA PCAT1 reduced CC cell proliferation and invasion potential. LncRNA PCAT1 targeted and inhibited miR-128-3p, and miR-128-3p targeted and inhibited SEC61A1 expression. miR-128-3p inhibition or SEC61A1 overexpression neutralized the suppressive role of silencing lncRNA PCAT1 in CC cell proliferation and invasion.

CONCLUSION: LncRNA PCAT1 was overexpressed in CC cells and facilitated CC cell proliferation and invasion via inhibition of miR-128-3p and promotion of SEC61A1.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app